The life cycle of human immunodeficiency virus type 1 (HIV-1) is intricately related to the
activation state of the host cells supporting viral replication. Although cellular activation is …

Co-infections contribute to HIV-related pathogenesis and often increase viral load in HIV-
infected people. We did a systematic review to assess the effect of treating key co-infections …

Summary Background Hepatitis C virus (HCV) infection is highly prevalent among HIV-1-
infected individuals, but its contribution to the morbidity and mortality of coinfected patients …

Hepatitis C virus (HCV) has emerged as an important etiologic agent of liver injury and
failure in patients infected with human immunodeficiency virus (HIV). The prevalence and …

Objective To assess hepatitis C virus (HCV) antibody prevalence in the EuroSIDA cohort,
along with survival, human immunodeficiency virus (HIV)–1 disease progression, virologic …

ContextConflicting reports exist regarding the effect of hepatitis C virus (HCV) on the
progression of human immunodeficiency virus (HIV) disease. ObjectiveTo assess the effect …

Summary The National Institutes of Health, the HIV Medicine Association of the Infectious
Diseases Society of America, and CDC have developed guidelines for treatment of …

During the 2003-04 influenza season, influenza A (H1), A (H3N2), and B viruses co-
circulated worldwide, and influenza A (H3N2) viruses predominated. Several Asian …

Hepatitis C virus (HCV) is an RNA virus of the Flaviviridae family and is a major cause of
chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Owing to shared routes of …

Since the decline in HIV-related morbidity and mortality after introduction of highly active
antiretroviral therapy (HAART) in 1996, liver disease caused by chronic infection with …